Federal Register / Vol. 62, No. 64 / Thursday, April 3, 1997 / Notices 15939

6(a) of the National Cooperative

Research and Production Act of 1993,

15 U.S.C. § 4301 et seq. (‘‘the Act’’), The

Asymetrical Digital Subscriber Line

Forum (‘‘ADSL’’) has filed written

notifications simultaneously with the

Attorney General and the Federal Trade

Commission disclosing changes in its

membership. The notifications were

filed for the purpose of extending the

Act’s provisions limiting the recovery of

antitrust plaintiffs to actual damages

under specified circumstances.

Specifically, the following companies

have joined ADSL: 3Com, San Diego,

CA; AG Communication Systems,

Phoenix, AZ; Amati Communications,

San Jose, CA; Ariel Corporation,

Cranberry, NJ; AT&T Laboratories,

Holmedel, NJ; BellSouth, Atlanta, GA;

Cascade Communications, Westford,

MA; Cisco Systems, San Jose, CA; DTI,

London, UNITED KINGDOM; ECI

Telecom, Inc., Altamonte Springs, FL;

France Telecom, Lannion, FRANCE;

Global Village Communications,

Sunnyvale, CA; GlobeSpan

Technologies, Largo, FL; and Vertel, El

Segundo, CA.

ADC Fibermux has changed its name

to ADC Telecommunications; AT&T

Paradyne has changed its name to

Paradyne; and Ericsson Schrack has

changed its name to Ericsson Austria.

GTE Labs and Racal-Datacom have

cancelled their membership in ADSL.

No other changes have been made in

the membership, nature or objectives of

ADSL. Membership remains open, and

ADSL intends to file additional written

notifications disclosing all changes in

membership.

On May 15, 1995, ADSL filed its

original notification pursuant to Section

6(a) of the Act. The Department of

Justice published a notice in the Federal

Register pursuant to Section 6(b) of the

Act on July 25, 1995 (60 FR 38058).

Constance K. Robinson,

Director of Operations, Antitrust Division.

[FR Doc. 97–8458 Filed 4–2–97; 8:45 am]

BILLING CODE 4410–11–M

Notice Pursuant to the National

Cooperative Research and Production

Act of 1993; Hart Communication

Foundation

Notice is hereby given that, on

December 18, 1996, pursuant to Section

6(a) of the National Cooperative

Research and Production Act of 1993,

15 U.S.C. § 4301 et seq. (‘‘the Act’’), Hart

Communication Foundation (‘‘HCF’’)

has filed written notifications

simultaneously with the Attorney

General and the Federal Trade

Commission disclosing changes in

membership. The notifications were

filed for the purpose of extending the

Act’s provisions limiting the recovery of

antitrust plaintiffs to actual damages

under specified circumstances.

Specifically, the identities of the new

members are: Analog Devices, Limerick,

IRELAND; Bopp & Reuther Messtechnik

GmbH, Mannheim, GERMANY; Brooks

Instrument, Hatfield, PA; Harold Beck &

Sons, Inc., Newtown, PA; Hersey

Measurement Company, Spartanburg,

SC; Institute of Automatic Control and

Robotics, Warszawa, POLAND;

Kamstrup A/S, Aabyhoj, DENMARK;

Knick Electronische MeBgerate GmbH

&, Berlin, GERMANY; MMG Automatika

Muvek Rt, Budapest, HUNGARY;

Ohmart Corporation, Cincinnati, OH;

Pondus Instruments AB, Vallingby,

SWEDEN; PR electronics A/S, Ronde,

DENMARK: Rittmeyer Ltd. Measuring

Control, Zug, SWITZERLAND; Ronan I/

O, Woodland Hills, CA; SMC

Corporation, Tsukuba-gun, Ibaraki-ken,

JAPAN; Toshiba Corporation, MinttoKu, Tokyo, JAPAN; and Valtek

International, Springville, UT.

No other changes have been made in

the membership, nature and objectives

of the consortium. Membership in HCF

remains open, and HCF intends to file

additional written notifications

disclosing all changes in membership.

On March 17, 1994, HCF filed its

original notification pursuant to Section

6(a) of the Act. The Department of

Justice published a notice in the Federal

Register pursuant to Section 6(b) of the

Act on May 5, 1994 (59 FR 23234). The

last notification was filed with the

Department on September 28, 1995. A

notice was published in the Federal

Register pursuant to Section 6(b) of the

Act on February 13, 1996 (61 FR 5569).

Constance K. Robinson,

Director of Operations, Antitrust Division.

[FR Doc. 97–8455 Filed 4–2–97; 8:45 am]

BILLING CODE 4410–11–M

Notice Pursuant to the National

Cooperative Research and Production

Act of 1993; International

Pharmaceutical Aerosol Consortium

for Toxicology Testing of HFA–227

(IPACT–II)

Notice is hereby given that, on March

6, 1997, pursuant to Section 6(a) of the

National Cooperative Research and

Production Act of 1993, 15 U.S.C.

§ 4301 et seq. (‘‘the Act’’), the

International Pharmaceutical Aerosol

Consortium for Toxicology Testing of

HFA–227 (‘‘IPACT–II’’) has filed written

notifications simultaneously with the

Attorney General and the Federal Trade

Commission disclosing a change in the

name of one of its members. The

notifications were filed for the purpose

of extending the Act’s provisions

limiting the recovery of antitrust

plaintiffs to actual damages under

specified circumstances. Specifically, as

the result of a merger, Ciba-Geigy

Limited, Basel, Switzerland, an original

party to IPACT–II, is now known as

Novartis Pharma, Inc., Basel,

Switzerland.

No other changes have been made in

either the membership or planned

activity of IPACT–II. Membership in

this group research project remains

open, and IPACT–II intends to file

additional written notification

disclosing all changes in membership.

On February 21, 1991, IPACT–II filed

its original notification pursuant to

Section 6(a) of the Act. The Department

of Justice published a notice in the

Federal Register pursuant to Section

6(b) of the Act on April 2, 1991 (56 FR

13489).

The last notification was filed with

the Department on April 15, 1996. The

Department of Justice published a notice

in the Federal Register on May 14, 1996

(61 FR 24331).

Constance K. Robinson,

Director of Operations, Antitrust Division.

[FR Doc. 97–8453 Filed 4–2–97; 8:45 am]

BILLING CODE 4410–11–M

Notice Pursuant to the National

Cooperative Research and Production

Act of 1993; International

Pharmaceutical Aerosol Consortium

for Toxicology Testing of HFA–134a

(IPACT–I)

Notice is hereby given that, on March

6, 1997, pursuant to Section 6(a) of the

National Cooperative Research and

Production Act of 1993, 15 U.S.C.

§ 4301 et seq. (‘‘the Act’’), the

International Pharmaceutical Aerosol

Consortium for Toxicology Testing of

HFA–134a (‘‘IPACT–I’’) has filed

written notifications simultaneously

with the Attorney General and the

Federal Trade Commission disclosing a

change in the name of one of its

members. The notifications were filed

for the purpose of extending the Act’s

provisions limiting the recovery of

antitrust plaintiffs to actual damages

under specified circumstances.

Specifically, as a result of a merger,

Ciba-Geigy Limited, Basel, Switzerland,

is now known as Novartis Pharma, Inc.,

Basel, Switzerland.

No other changes have been made in

either the membership or planned

activity of IPACT–I. Membership in this

group research project remains open,

and IPACT–I intends to file additional